From Ocean to Lab: How Marine Biomedicine Has the Potential to Transform Fertility Care
- Eric Lacy, PhD
- Apr 23
- 2 min read
Updated: Aug 26
When people think of fertility science, they rarely picture the ocean. But beneath the surface of our planet’s vast marine ecosystems lies an untapped frontier of therapeutic potential—one that could reshape how we approach reproductive health and fertility care.
As a researcher and founder working at the intersection of marine biomedicine and fertility, I’ve spent the better part of the last decade exploring how marine-derived compounds can solve some of the most persistent challenges in reproductive medicine. And here’s what I’ve learned: nature has already done much of the hard work. We just have to listen.

The Ocean: A Living Library of Bioactive Compounds
Marine organisms have evolved sophisticated biochemical pathways to survive extreme environments—pressures, temperatures, and microbial threats far beyond what we encounter on land. In doing so, they’ve created compounds with unique mechanisms of action that can be harnessed for human health.
From antifungal agents isolated from sponges to cancer therapies inspired by sea squirts, marine biomedicine is already a proven source of pharmaceutical innovation. But its application to fertility science is only just beginning.
Fertility Science Needs New Tools
The challenges facing fertility care today are significant:
Sperm quality is declining globally, yet treatment options for male infertility remain limited and under-researched.
Assisted reproductive technologies (ART) are expensive and often inefficient, with low success rates per cycle.
Patients are increasingly seeking more personalized, non-invasive, and supportive fertility solutions—both in clinics and at home.
This is where marine biomedicine comes in.
Marine Compounds for Reproductive Innovation
At Aqua Fem, we’re exploring how specific marine-derived compounds can enhance sperm motility—a critical factor in male fertility that affects the success of IUI and IVF procedures.
Our lead compound, “AF,” originated in marine bio research and has shown early promise in improving sperm performance when added to sperm washing media. But its potential goes far beyond the lab. We’re developing AF as both a clinical adjunct and an over-the-counter fertility support product—bringing advanced science directly to the people who need it most.
This kind of innovation is only possible when we bridge two worlds: the deep biological wisdom of marine ecosystems and the precision of reproductive science.
What’s Next: Toward More Sustainable, Accessible Fertility Care
Marine biomedicine offers not only novel mechanisms of action, but also the potential for sustainable sourcing, scalable production, and multifunctional applications—from ART optimization to consumer health products.
As we face growing demand for fertility care globally, particularly for men, we need to look beyond traditional compounds and think expansively about where the next wave of solutions will come from.
My bet? The ocean.
Comments